BridgeMD
New treatment option for Patellofemoral Pain Syndrome
Official title Isokinetic Training With Blood Flow Restriction for Patellofemoral Pain Syndrome
ClinicalTrials.gov ID: NCT07600827
What this study is testing
- What it's testing
- This randomized controlled trial aims to investigate the effects of isokinetic training combined with blood flow restriction (BFR) in individuals with patellofemoral pain syndrome (PFPS).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40
You may be able to join if
- Participants aged 18 to 40 years.
- Clinical diagnosis of patellofemoral pain syndrome (PFPS).
- Presence of anterior or retropatellar knee pain for at least 3 months.
- Pain provoked by at least two activities that increase patellofemoral joint load, including squatting, stair climbing, running, jumping, prolonged...
- Average knee pain intensity of ≥3 on a 10-point visual analog scale (VAS) during aggravating activities.
You likely can't join if
- History of knee surgery or significant trauma to the lower extremity within the previous 12 months.
- Clinical evidence of other knee disorders, including ligament injury, meniscal injury, patellar instability, osteoarthritis, or tendinopathy.
- Presence of neurological, cardiovascular, or systemic musculoskeletal disorders that may affect lower limb function or exercise participation.
- Current participation in other structured lower extremity rehabilitation or strength training programs.
- Contraindications to blood flow restriction training, including uncontrolled hypertension, vascular disease, thromboembolic disorders, or clotting...
- Use of pain-relieving injections or surgical interventions for knee pain within the previous 6 months.
See the full eligibility criteria
- Participants aged 18 to 40 years.
- Clinical diagnosis of patellofemoral pain syndrome (PFPS).
- Presence of anterior or retropatellar knee pain for at least 3 months.
- Pain provoked by at least two activities that increase patellofemoral joint load, including squatting, stair climbing, running, jumping, prolonged sitting, or kneeling.
- Average knee pain intensity of ≥3 on a 10-point visual analog scale (VAS) during aggravating activities.
- Ability to participate in exercise training and attend scheduled intervention sessions.
- Willingness to provide written informed consent.
- History of knee surgery or significant trauma to the lower extremity within the previous 12 months.
- Clinical evidence of other knee disorders, including ligament injury, meniscal injury, patellar instability, osteoarthritis, or tendinopathy.
- Presence of neurological, cardiovascular, or systemic musculoskeletal disorders that may affect lower limb function or exercise participation.
- Current participation in other structured lower extremity rehabilitation or strength training programs.
- Contraindications to blood flow restriction training, including uncontrolled hypertension, vascular disease, thromboembolic disorders, or clotting abnormalities.
- Use of pain-relieving injections or surgical interventions for knee pain within the previous 6 months.
- Pregnancy.
- Inability to complete the assessment or intervention procedures.
The study team makes the final eligibility decision.
Where it's taking place
- Nanjing, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanjing, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.